Warning : Undefined property: WP_Error::$slug in
/var/www/medicalconferences/wp-content/themes/writers-blogily-new/category.php on line
41
Featured articles
Editor Prof. Gert Ossenkoppele, Amsterdam UMC, the Netherlands Conference ASH 2024
29 January 2025 10:41
Expert Prof. Mats Jerkeman, Skane University Hospital and Lund University, Sweden Trial Phase 2, ALTAMIRA Conference ASH 2024
23 December 2024 15:15
Presented By Robert van den Heuvel, Medicom Conference ASH 2024
18 December 2024 15:33
ASH 2024
Editor Prof. Gert Ossenkoppele, Amsterdam UMC, the Netherlands Conference ASH 2024
29 January 2025 10:41
Presented By Prof. Laurie Sehn, University of British Columbia, Canada Trial Phase 3, inMIND Conference ASH 2024 Type Peer-reviewed article
29 January 2025 10:34
Presented By Dr Jing-Zhou Hou, University of Pittsburgh Medical Center, PA, USA; Dr Sameh Gaballa, Lee Moffitt Cancer Center, FL, USA Trial Phase 1 Conference ASH 2024 Type Peer-reviewed article
29 January 2025 10:31
Presented By Dr Catherine Diefenbach, NYU Langone Health, NY, USA Trial Phase 1, BO42203 Conference ASH 2024 Type Peer-reviewed article
29 January 2025 10:29
Presented By Prof. Marie JosƩ Kersten, Amsterdam University Medical Center, the Netherlands Trial Phase 1/2, ATALANTA-1 Conference ASH 2024 Type Peer-reviewed article
29 January 2025 10:27
Presented By Prof. Sattva Neelapu, MD Anderson Cancer Center, TX, USA Trial Phase 2, ZUMA-5 Conference ASH 2024 Type Peer-reviewed article
29 January 2025 10:25
Presented By Dr Timothy Fenske, Medical College of Wisconsin, WI, USA Trial Phase 3, EA4151 Conference ASH 2024 Type Peer-reviewed article
29 January 2025 10:23
Presented By Prof. Mark Levis, Johns Hopkins University, MD, USA Trial Phase 3, QuANTUM-First Conference ASH 2024 Type Peer-reviewed article
29 January 2025 10:20
Presented By Dr Ghayas Issa, MD Anderson Cancer Center, TX, USA Trial Phase 1/2, SAVE Conference ASH 2024 Type Peer-reviewed article
29 January 2025 10:17
Presented By Dr Daniel Pollyea, University of Colorado, CO, USA Conference ASH 2024 Type Peer-reviewed article
29 January 2025 10:14
Presented By Dr Jennifer Marvin-Peek, MD Anderson Cancer Center, TX, USA Trial Phase 1/2 Conference ASH 2024 Type Peer-reviewed article
29 January 2025 10:12
Presented By Dr Priyanka Mehta, University Hospitals Bristol NHS Foundation Trust, UK Trial Phase 3, AML19 Conference ASH 2024 Type Peer-reviewed article
29 January 2025 10:09
Presented By Dr Ioannis Mantzaris, Montefiore Medical Center, NY, USA Trial Phase 1 Conference ASH 2024 Type Peer-reviewed article
29 January 2025 10:07
Presented By Prof. Daniel DeAngelo, Dana-Farber Cancer Institute, MA, USA Trial Phase 3 Conference ASH 2024 Type Peer-reviewed article
29 January 2025 10:05
Presented By Dr Ibrahim Aldoss, City of Hope, CA, USA Trial Phase 2, AUGMENT-101 Conference ASH 2024 Type Peer-reviewed article
29 January 2025 10:03
Presented By Dr Rachel Rau, University of Washington, WA, USA Trial Phase 3, AALL1731 Conference ASH 2024 Type Peer-reviewed article
29 January 2025 09:57
Presented By Dr Charlotte Pawlyn, Institute of Cancer Research, UK Trial Phase 3, Myeloma XI/XI+ Conference ASH 2024 Type Peer-reviewed article
29 January 2025 09:53
Presented By Prof. Meletios Dimopoulos, University of Athens, Greece Trial Phase 3, AQUILA Conference ASH 2024 Type Peer-reviewed article
29 January 2025 09:49
Presented By Prof. Luciano Costa, University of Alabama at Birmingham, AL, USA Trial Phase 1/2, CA057-003 Conference ASH 2024 Type Peer-reviewed article
29 January 2025 09:47
Presented By Prof. Salomon Manier, University of Lille, France Trial Phase 3, IFM2017-03 Conference ASH 2024 Type Peer-reviewed article
29 January 2025 09:44
Presented By Prof. Sonja Zweegman, Amsterdam University Medical Centre, the Netherlands Trial Phase 3, CEPHEUS Conference ASH 2024 Type Peer-reviewed article
29 January 2025 09:42
Presented By Dr Sophia Delicou, Hippocrates General Hospital, Greece Trial Phase 2, HIBISCUS Conference ASH 2024 Type Peer-reviewed article
29 January 2025 09:40
Presented By Prof. David Kuter, Massachusetts General Hospital, MA, USA Trial Phase 3, LUNA 3 Conference ASH 2024 Type Peer-reviewed article
29 January 2025 09:38
Presented By Prof. Francis Couturaud, Brest University Hospital, France Trial Phase 3, RENOVE Conference ASH 2024 Type Peer-reviewed article
29 January 2025 09:36
Presented By Dr FranƧoise Bernaudin, Centre Hospitalier Intercommunal Creteil, France Trial DREPAGREFFE-2 Conference ASH 2024 Type Peer-reviewed article
29 January 2025 09:33
Presented By Dr Yvonne Dei-Adomakoh, Korle-bu Teaching Hospital, Ghana Trial Phase 2, PIVOT Conference ASH 2024 Type Peer-reviewed article
29 January 2025 09:30
Presented By Dr Efstathios Kastritis, University of Athens, Greece Trial Phase 3, ANDROMEDA Conference ASH 2024 Type Peer-reviewed article
29 January 2025 09:27
Expert Prof. Mats Jerkeman, Skane University Hospital and Lund University, Sweden Trial Phase 2, ALTAMIRA Conference ASH 2024
23 December 2024 15:15
Presented By Robert van den Heuvel, Medicom Conference ASH 2024
18 December 2024 15:33
EHA 2024
Presented By Dr Consuelo Bertossi, University Hospital Ulm, Germany Conference EHA 2024 Type Peer-reviewed article
12 August 2024 15:11
Presented By Prof. Naveen Pemmaraju, MD Anderson Cancer Center, TX, USA Trial Phase 3, TRANSFORM-1 Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:28
Presented By Dr Raajit Rampal, Memorial Sloan Kettering Cancer Center, NY, USA Trial Phase 3, MANIFEST-2 Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:28
Presented By Dr Marc Hoffman, The University of Kansas Cancer Center, KS, USA Trial Phase 1, CC-220-DLBCL-001 Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:27
Presented By Dr Marcel Nijland, University Medical Center Groningen, the Netherlands Trial Phase 2, HOVON 151 Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:27
Presented By Prof. Paolo Ghia, University Vita-Salute San Raffaele, Italy Trial Phase 3, SEQUOIA Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:27
Presented By Prof. Arnon Kater, University of Amsterdam, the Netherlands Trial Phase 1/2, EPCORE CLL-1 Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:27
Presented By Dr Evgenii Shumilov, University of MĆ¼nster, Germany Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:27
Presented By Prof. Michael Wang, University of Texas, TX, USA Trial Phase 3, ECHO Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:26
Presented By Dr Sarit Assouline, Jewish General Hospital, Canada Trial Phase 1/2 Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:26
Presented By Prof. Ali Taher, American University of Beirut, Lebanon Trial Phase 3, ENERGIZE Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:26
Presented By Prof. Renchi Yang, Chinese Academy of Medical Sciences, China Trial Phase 3, ESLIM-01 Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:26
Presented By Dr Rachael Grace, Harvard Medical School, MA, USA Trial Phase 3, AVA-PED-301 Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:26
Presented By Dr Rabi Hanna, Cleveland Clinic, OH, USA Trial Phase 1/2, RUBY Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:25
Presented By Dr Abhishek Maiti, MD Anderson Cancer Center, TX, USA Trial Phase 1 Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:25
Presented By Prof. Jose Maria Ribera, Josep Carreras Leukaemia Research Institute, Spain Trial Phase 3, PhALLCON Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:25
Presented By Prof. Uwe Platzbecker, Leipzig University Hospital, Germany Trial Phase 3, TUD-APOLLO-064 Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:25
Presented By Prof. Andreas Hochhaus, Jena University Hospital, Germany Trial Phase 3, ASC4FIRST Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:25
Presented By Dr Ibrahim Aldoss, City of Hope National Medical Center, CA, USA Trial Phase 2, AUGMENT-101 Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:24
Presented By Dr Wei-Ying Jen, MD Anderson Cancer Center, TX, USA Trial Phase 2 Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:20
Presented By Prof. Amer Zeidan, Yale University, CT, USA Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:19
Presented By Dr David Sallman, Moffitt Cancer Center, FL, USA Trial Phase 3, ENHANCE Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:19
Presented By Dr Anne Sophie Kubasch, University of Leipzig, Germany Trial Phase 2, RELAZA2 Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:19
Presented By Dr Anna Staffas, University of Gothenburg, Sweden Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:19
Presented By Prof. Thierry Facon, University of Lille, France Trial Phase 3, IMROZ Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:19
Presented By Prof. Pieter Sonneveld, Erasmus University Medical Center, the Netherlands Trial Phase 3, PERSEUS Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:17
Presented By Prof. Marc Raab, University Hospital Heidelberg, Germany Trial Phase 3, GMMG-HD7 Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:17
Presented By Dr Binod Dhakal, Medical College of Wisconsin, WI, USA Trial Phase 1 Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:17
Presented By Prof. Meletious Dimopoulos, University of Athens, Greece Trial Phase 3, DREAMM 8 Conference EHA 2024 Type Peer-reviewed article
12 August 2024 14:16
Editor Prof. Gert Ossenkoppele, Amsterdam UMC, the Netherlands Conference EHA 2024
12 August 2024 14:12
Expert Prof. C. Ola Landgren, University of Miami, FL, USA Conference EHA 2024
10 July 2024 16:53
Presented By Robert van den Heuvel, Medicom Conference EHA 2024
2 July 2024 21:58
ASH 2023
Editor Prof. Gert Ossenkoppele, Amsterdam UMC, the Netherlands Conference ASH 2023
7 February 2024 15:14
Presented By Prof. Alexander Perl, University of Pennsylvania, PA, USA Trial Phase 3, QuANTUM-First Conference ASH 2023 Type Peer-reviewed article
7 February 2024 15:05
Presented By Dr Jad Othman, Royal North Shore Hospital, Australia Conference ASH 2023 Type Peer-reviewed article
7 February 2024 15:04
Presented By Dr Musa Yilmaz, MD Anderson Cancer Center, TX, USA Trial Phase 1/2 Conference ASH 2023 Type Peer-reviewed article
7 February 2024 15:04
Presented By Dr Ibrahim Aldoss, City of Hope National Medical Center, CA, USA Trial Phase 2, AUGMENT-101 Conference ASH 2023 Type Peer-reviewed article
7 February 2024 15:04
Presented By Prof. Martin Schrappe, Hong Kong College of Paediatricians, China Trial Phase 3, AIEOP-BFM ALL 2017 Conference ASH 2023 Type Peer-reviewed article
7 February 2024 15:02
Presented By Dr Xiaoyuan Gong, Chinese Academy of Medical Sciences, China Trial Phase 2 Conference ASH 2023 Type Peer-reviewed article
7 February 2024 15:02
Presented By Dr Moritz FĆ¼rstenau, University of Cologne, Germany Trial Phase 2, CLL2-BAAG Conference ASH 2023 Type Peer-reviewed article
7 February 2024 15:01
Presented By Prof. Bertram Glass, Helios Klinikum Berlin-Buch, Germany Trial Phase 2, ASTRAL Conference ASH 2023 Type Peer-reviewed article
7 February 2024 15:00
Presented By Dr Paolo Strati, MD Anderson Cancer Center, TX, USA Trial Phase 2 Conference ASH 2023 Type Peer-reviewed article
7 February 2024 15:00
Presented By Dr Charalambos Andreadis, UniversityĀ of California San Francisco, USA Trial Phase 3, A051301/BMT-CTN 1201 Conference ASH 2023 Type Peer-reviewed article
7 February 2024 14:59
Presented By Dr Elizabeth Budde, City of Hope National Medical Center, CA, USA Trial Phase 1/2 Conference ASH 2023 Type Peer-reviewed article
7 February 2024 14:59
Presented By Prof. Michael Wang, University of Texas, TX, USA Trial Phase 3, SYMPATICO Conference ASH 2023 Type Peer-reviewed article
7 February 2024 14:59
Presented By Prof. Meletios Dimopoulos, University of Athens, Greece Trial Phase 3, CANDOR Conference ASH 2023 Type Peer-reviewed article
7 February 2024 14:58
Presented By Prof. Francesca Gay, University of Torino, Italy Trial Phase 3, IsKia Conference ASH 2023 Type Peer-reviewed article
7 February 2024 14:57
Presented By Prof. Naveen Pemmaraju, MD Anderson Cancer Center, TX, USA Trial Phase 3, TRANSFORM-1 Conference ASH 2023 Type Peer-reviewed article
7 February 2024 14:57
Presented By Prof. Ruben Mesa, Wake Forest Baptist Comprehensive Cancer Center, NC, USA Trial Phase 3, Simplify-1, MOMENTUM Conference ASH 2023 Type Peer-reviewed article
7 February 2024 14:57
Presented By Dr Trine Knudsen, University Hospital Odense, Denmark Trial Phase 3, DALIAH Conference ASH 2023 Type Peer-reviewed article
7 February 2024 14:57
Presented By Prof. Antonio Risitano, University of Naples, Italy Trial Phase 3, APPLY-PNH Conference ASH 2023 Type Peer-reviewed article
7 February 2024 14:56
Presented By Prof. Catherine Broome, Georgetown University, DC, USA Trial Phase 3, ADVANCE IV Conference ASH 2023 Type Peer-reviewed article
7 February 2024 14:56
Presented By Prof. Michael Tarantino, University of Illinois, IL, USA Trial Phase 1/2, LUNA 2 Conference ASH 2023 Type Peer-reviewed article
7 February 2024 14:55
Presented By Dr Julie Jaffray, Rady Childrenās Hospital-San Diego, CA, USA Conference ASH 2023 Type Peer-reviewed article
7 February 2024 14:55
Presented By Prof. Daniel Wolff, University Hospital Regensburg, Germany Trial Phase 2, AGAVE-201 Conference ASH 2023 Type Peer-reviewed article
7 February 2024 14:54
Presented By Prof. Keith McCrae, Cleveland Clinic, OH, USA Trial Phase 2, PATH-HHT Conference ASH 2023 Type Peer-reviewed article
7 February 2024 14:54
Presented By Dr Sean Wen, University of Cambridge, UK Conference ASH 2023 Type Peer-reviewed article
7 February 2024 14:54
Presented By Prof. Pieter Sonneveld, Erasmus MC, the Netherlands Trial Phase 3, Perseus Conference ASH 2023 Type Peer-reviewed article
6 February 2024 16:34
Expert Dr Eliza Hawkes, Olivia Newton-John Cancer Wellness & Research Centre, Australia Trial Phase 2, WAMM Conference ASH 2023
4 January 2024 14:30
Presented By Robert van den Heuvel, Medicom Conference ASH 2023
4 January 2024 10:55
Expert Prof. Jeff Sharman , The US Oncology Network and Willamette Valley Cancer Institute, Oregon, USA Trial Phase 3, ELEVATE-TN Conference ASH 2023
18 December 2023 18:14
EHA 2023
Presented By Prof. Gert Ossenkoppele, Amsterdam UMC, the Netherlands Conference EHA 2023
2 August 2023 18:13
Presented By Dr Matteo Della Porta, Humanitas Cancer Centre Milan, Italy Trial Phase 3, COMMANDS Conference EHA 2023 Type Peer-reviewed article
2 August 2023 17:39
Presented By Dr Marina Kremyanskaya, Mount Sinai, New York, USA Trial Phase 2, REVIVE Conference EHA 2023 Type Peer-reviewed article
2 August 2023 17:34
Presented By Dr Nili Furer, Weizmann Institute of Science, Israel Conference EHA 2023 Type Peer-reviewed article
2 August 2023 17:28
Presented By Dr Mathis Mottelson, Copenhagen University Hospital, Denmark Conference EHA 2023 Type Peer-reviewed article
2 August 2023 17:05
Presented By Dr Richard Schlenk, University of Heidelberg, Germany Trial Phase 3, QuANTUM-First Conference EHA 2023 Type Peer-reviewed article
2 August 2023 16:54
Presented By Dr Amir Fathi, Massachusetts General Hospital, Massachusetts, USA Trial Phase 1/2, KOMET-001 Conference EHA 2023 Type Peer-reviewed article
2 August 2023 16:51
Presented By Dr Mark Levis, Johns Hopkins Hospital, Maryland, USA Trial MORPHO Conference EHA 2023 Type Peer-reviewed article
2 August 2023 16:45
Presented By Prof. Timothy Hughes, University of Adelaide, Australia Trial Phase 3, ASCEMBL Conference EHA 2023 Type Peer-reviewed article
2 August 2023 16:41
Presented By Dr Pau Montesinos, University of Valencia, Spain Trial Phase 2, QUIWI Conference EHA 2023 Type Peer-reviewed article
2 August 2023 16:38
Presented By Dr Jens Panse, University of Aachen, Germany Trial Phase 1 Conference EHA 2023 Type Peer-reviewed article
2 August 2023 16:32
Presented By Dr Jun-Ho Jang, Samung Medical Center, South Korea Trial Phase 2 Conference EHA 2023 Type Peer-reviewed article
2 August 2023 16:23
Presented By Dr Maurizio Martelli, University Sapienza Roma, Italy Trial IELSG37 Conference EHA 2023 Type Peer-reviewed article
2 August 2023 16:16
Presented By Dr Paolo Caimi, Cleveland Clinic, Ohio, USA Trial Phase 2, LOTIS-2 Conference EHA 2023 Type Peer-reviewed article
2 August 2023 16:12
Presented By Dr Takahiro Kumode, Kindai University, Japan Trial Phase 2, MIRAGE Conference EHA 2023 Type Peer-reviewed article
2 August 2023 16:05
Presented By Dr Michael Clausen, Lillebaelt Hospital, Denmark Trial Phase 1/2, EPCORETM NHL-2 Conference EHA 2023 Type Peer-reviewed article
2 August 2023 15:43
Presented By Dr Jeffrey Matous, Colorado Blood Cancer Institute, Colorado, USA Trial Phase 1, MajesTEC-2 Conference EHA 2023 Type Peer-reviewed article
2 August 2023 15:21
Presented By Prof. Sebastian Grosicki, Medical University of Silesia, Poland Trial Phase 1/2, DREAMM 5 Conference EHA 2023 Type Peer-reviewed article
2 August 2023 15:15
Presented By Dr Hermann Einsele, University of WĆ¼rzburg, Germany Trial Phase 3, CARTITUDE-4 Conference EHA 2023 Type Peer-reviewed article
2 August 2023 15:08
Presented By Robert van den Heuvel, Medicom Conference EHA 2023
28 June 2023 07:19
EBMT 2023
Presented By Dr Emily Liang, University of Washington, WA, USA Trial Phase 2 Conference EBMT 2023 Type Peer-reviewed article
15 June 2023 17:31
Presented By Dr Carmelo Gurnari, Cleveland Clinic, OH, USA & Tor Vergata University, Italy Conference EMBT 2023 Type Peer-reviewed article
15 June 2023 17:27
Presented By Dr Katy Rezvani, MD Anderson Cancer Center, TX, USA Conference EBMT 2023 Type Peer-reviewed article
15 June 2023 17:20
Presented By Dr Anna Sureda, Catalan Institute of Oncology, Spain Conference EBMT 2023 Type Peer-reviewed article
15 June 2023 17:15
Presented By Prof. Josu de la Fuente, Imperial College London, UK Conference EBMT 2023 Type Peer-reviewed article
15 June 2023 17:06
Presented By Prof. Mohamad Mohty, Sorbonne University, France Conference EBMT 2023 Type Peer-reviewed article
15 June 2023 16:59
Presented By Prof. Ronjon Chakraverty, University of Oxford, UK Conference EBMT 2023 Type Peer-reviewed article
15 June 2023 16:54
Presented By Dr Paula RodrĆguez-Otero, Clinica Universidad de Navarra, Spain Trial Phase 3, KarMMa-3 Conference EBMT 2023 Type Peer-reviewed article
15 June 2023 16:48
Editor Prof. Gert Ossenkoppele, Amsterdam UMC, the Netherlands Conference EBMT 2023
15 June 2023 13:27
Presented By Prof. Salomon Manier, Lille University Hospital, France Trial Phase 3, CARTITUDE-6 Conference EBMT 2023 Type Peer-reviewed article
14 June 2023 20:23
Presented By Dr Hani Hassoun, Memorial Sloan Kettering Cancer Center, NY, USA Trial Phase 3, DETERMINATION Conference EBMT 2023 Type Peer-reviewed article
14 June 2023 20:14
Presented By Prof. Radovan Vrhovac, University Hospital Centre Zagreb, Croatia Trial Phase 3, QuANTUM-First Conference EMBT 2023 Type Peer-reviewed article
14 June 2023 20:07
Presented By Dr Ayman Sayyed, University of Toronto, Canada Conference EBMT 2023 Type Peer-reviewed article
14 June 2023 20:02
Presented By Prof. Olaf Penack, CharitƩ University Hospital of Berlin, Germany Conference EBMT 2023 Type Peer-reviewed article
14 June 2023 19:55
Presented By Dr Gesine Bug, Goethe University Frankfurt, Germany Conference EBMT 2023 Type Peer-reviewed article
14 June 2023 19:48
Presented By Prof. Edmund Waller, Emory University, GA, USA Conference EBMT 2023 Type Peer-reviewed article
14 June 2023 19:42
Presented By Robert van den Heuvel, Medicom Conference EBMT 2023
14 May 2023 20:09
Expert Dr Sergio Giralt, Memorial Sloan Kettering Cancer Center, USA Trial Phase 3, KarMMa-3
17 April 2023 12:45
ASH 2022
Editor Prof. Gert Ossenkoppele, Amsterdam UMC, the Netherlands Conference ASH 2022
20 February 2023 13:27
Presented By Dr Steven Grover, University of North Carolina, NC, USA Conference ASH 2022 Type Peer-reviewed article
20 February 2023 13:18
Presented By Prof. Stacy Croteau, Harvard Medical School, MA, USA Trial Phase 1/2, SPK-8011 Conference ASH 2022 Type Peer-reviewed article
20 February 2023 13:16
Presented By Prof. Mark Walters; Prof. Franco Locatelli Trial LTF-303 Conference ASH 2022 Type Peer-reviewed article
20 February 2023 13:14
Presented By Prof. Federico Stella, UniversitĆ degli Studi di Milano, Italy Conference ASH 2022 Type Peer-reviewed article
20 February 2023 13:11
Presented By Prof. RĆ©gis de Latour, Saint-Louis Hospital, France Trial Phase 3, Apply-PNH Conference ASH 2022 Type Peer-reviewed article
20 February 2023 13:09
Presented By Prof. Shernan Holtan, University of Minnesota, MN, USA Trial Phase 3, BMT CTN 1703 Conference ASH 2022 Type Peer-reviewed article
20 February 2023 13:05
Presented By Prof. Saskia Middeldorp, Radboud UMC, the Netherlands Trial ALIFE2 Conference ASH 2022 Type Peer-reviewed article
20 February 2023 13:01
Presented By Prof. Catherine Broome, Georgetown University, Washington DC, USA Trial Phase 3, ADVANCE Conference ASH 2022 Type Peer-reviewed article
20 February 2023 12:57
Presented By Dr Nardeen Ayad, Massachusetts General Hospital, MA, USA Conference ASH 2022 Type Peer-reviewed article
20 February 2023 12:50
Presented By Dr Edimara Reis, Incyte Corporation, DE, USA Conference ASH 2022 Type Peer-reviewed article
20 February 2023 12:47
Presented By Dr Nabih Maslah, UniversitƩ Paris CitƩ, France Conference ASH 2022 Type Peer-reviewed article
20 February 2023 12:43
Presented By Prof. Martin Dreyling, University Hospital Munich, Germany Trial Phase 3, Triangle Conference ASH 2022 Type Peer-reviewed article
20 February 2023 12:39
Presented By Prof. Gerald Illerhaus, Klinikum Stuttgart, Germany Trial Phase 3, MATRix/IELSG43 Conference ASH 2022 Type Peer-reviewed article
20 February 2023 12:37
Presented By Prof. Won-Seog Kim, Samsung Medical Center, South Korea Trial Phase 2, ELM-2 trial Conference ASH 2022 Type Peer-reviewed article
20 February 2023 12:30
Presented By Dr Yago Nieto, University of Texas, TX, USA Conference ASH 2022 Type Peer-reviewed article
20 February 2023 12:27
Presented By Dr Kai Rejeski, LMU Munich, Germany Conference ASH 2022 Type Peer-reviewed article
20 February 2023 12:23
Presented By Prof. Ajai Chari, Mount Sinai School of Medicine, NY, USA Trial Phase 1/2, MonumenTAL-1 Conference ASH 2022 Type Peer-reviewed article
20 February 2023 12:19
Presented By Prof. Nizar Bahlis, University of Calgary, Canada Trial Phase 2, MagnetisMM-3 Conference ASH 2022 Type Peer-reviewed article
20 February 2023 12:09
Presented By Prof. Shaji Kumar, Mayo Clinic, MN, USA Trial Phase 2, ASCENT Conference ASH 2022 Type Peer-reviewed article
20 February 2023 12:04
Presented By Dr Laura Notarfranchi, University of Parma, Italy Trial Phase 3, GEM2014MAIN Conference ASH 2022 Type Peer-reviewed article
20 February 2023 11:55
Presented By Dr Kai Rejeski, LMU Munich, Germany Conference ASH 2022 Type Peer-reviewed article
20 February 2023 11:52
Presented By Dr Sara Bringhen, UniversitĆ degli Studi di Torino, Italy Trial Phase 4, REAL-MM Conference ASH 2022 Type Peer-reviewed article
20 February 2023 11:47
Presented By Prof. Jennifer Brown, Dana Farber Cancer Institute, MA, USA Trial Phase 3, ALPINE Conference ASH 2022 Type Peer-reviewed article
20 February 2023 11:40
Presented By Prof. John Allan, Weill Cornell Medicine, NY, USA Trial Phase 2, CAPTIVATE Conference ASH 2022 Type Peer-reviewed article
20 February 2023 11:28
Presented By Prof. Nicholas Short, University of Texas, TX, USA Conference ASH 2022 Type Peer-reviewed article
20 February 2023 11:25
Presented By Mr Jad Othman, Guyās and St Thomasā NHS Foundation Trust, UK Conference ASH 2022 Type Peer-reviewed article
20 February 2023 11:20
Presented By Prof. Naval Daver, Anderson Cancer Center, TX, USA Trial Phase 3, ENHANCE-3 Conference ASH 2022 Type Peer-reviewed article
20 February 2023 11:17
Presented By Prof. Matthias Stelljes, University of Muenster, Germany Trial Phase 3, EATL3-ASAP Conference ASH 2022 Type Peer-reviewed article
20 February 2023 11:13
Presented By Prof. Mark Litzow, Mayo Clinic, MN, USA Trial Phase 3, ECOG-ACRIN-E1910 NCTN Conference ASH 2022 Type Peer-reviewed article
20 February 2023 11:07
Presented By Ms Amy Kirkwood, University College London, UK Trial UKALL 2011 Conference ASH 2022 Type Peer-reviewed article
20 February 2023 11:01
Presented By Robert van den Heuvel, Medicom Conference ASH 2022
5 January 2023 02:23
EHA 2022
Presented By Dr Yannik Severin, ETH Zurich, Switzerland Conference EHA 2022 Type News article
1 July 2022 11:54
Presented By Dr Harry Erba, Duke Cancer Institute, NC, USA Trial Phase 3, QuANTUM-First Conference EHA 2022 Type News article
1 July 2022 11:52
Presented By Prof. Nigel Russell, Guy's and St Thomas' NHS Foundation Trust, UK Trial Phase 3, AML19 Conference EHA 2022 Type News article
1 July 2022 11:49
Presented By Dr Petri Pƶlƶnen, St. Jude Children's Research Hospital, TN, USA Conference EHA 2022 Type News article
1 July 2022 11:45
Presented By Prof. Barbara Eichhorst, University Hospital Cologne, Germany Trial Phase 3, GAIA/CLL13 Conference EHA 2022 Type News article
1 July 2022 11:43
Presented By Dr Anna Sureda, University of Barcelona, Spain Trial Phase 3, ZUMA-7 Conference EHA 2022 Type News article
1 July 2022 11:40
Presented By Dr Paul Brƶckelmann, University Hospital of Cologne, Germany Trial Phase 2, AERN Conference EHA 2022 Type News article
1 July 2022 11:37
Presented By Prof. Martine Chamuleau, Amsterdam UMC, the Netherlands Trial Phase 3, HOVON/SAKK Conference EHA 2022 Type News article
1 July 2022 11:32
Presented By Dr Dominik Dytfeld, Poznan University of Medical Sciences, Poland Trial Phase 3, ATLAS Conference EHA 2022 Type News article
1 July 2022 11:24
Presented By Dr Paul Richardson, Dana-Farber Cancer Institute, MA, USA Trial Phase 3, DETERMINATION Conference EHA 2022 Type News article
1 July 2022 11:21
Presented By Prof. Srdan Verstovsek, University of Texas MD Anderson Cancer Center, TX, USA Trial Phase 3, MOMENTUM Conference EHA 2022 Type News article
1 July 2022 11:19
Presented By Prof. Marie Scully, University College London Hospitals, UK Trial Phase 3, post-HERCULES Conference EHA 2022 Type News article
1 July 2022 11:15
Presented By Prof. Maria Capellini, University of Milan, Italy Trial Phase 3, BELIEVE Conference EHA 2022 Type News article
1 July 2022 11:13
Presented By Prof. Franco Locatelli, University of Pavia, Italy Trial Phase 3, CLIMB THAL-111, CLIMB SCD-121 Conference EHA 2022 Type News article
1 July 2022 11:08
Presented By Dr Koneti Rao, National Institute of Health, MD, USA Trial Phase 3 Conference EHA 2022 Type News article
1 July 2022 11:05
ASH 2021 Focus on CAR T-Cell Therapy
Conference ASH 2021
3 March 2022 23:38
Presented By Dr Rachel Giles, Medicom Conference ASH 2021
3 March 2022 23:28
Expert Dr Kelly Kenzik, Institute for Cancer Outcomes and Survivorship, University of Alabama, USA Conference ASH 2021 Type News article
4 February 2022 11:36
Expert Dr Matthew J. Frank, Stanford University School of Medicine, USA Conference ASH 2021 Type News article
4 February 2022 11:30
Expert Dr Sattva S. Neelapu, MD Anderson Cancer Center, Houston, USA Trial ZUMA-12 Conference ASH 2021 Type News article
4 February 2022 11:25
Expert Dr Grzegorz Nowakowski, Mayo Clinic, Rochester, USA Trial Cohort study, RE-MIND2 Conference ASH 2021 Type News article
4 February 2022 11:08
Expert Dr Manali Kamdar, University of Colorado Cancer Center, Denver, USA Trial Phase 3, TRANSFORM Conference ASH 2021 Type News article
4 February 2022 10:28
Expert Dr Geoffrey Shouse, City of Hope Comprehensive Cancer Center, USA Conference ASH 2021 Type News article
4 February 2022 10:20
Expert Dr Emmanuel Bachy, Hospices Civils de Lyon, France Trial JULIET, ZUMA-1 Conference ASH 2021 Type News article
4 February 2022 10:15
Expert Dr Frederick Locke, Moffitt Cancer Cancer, Tampa, Florida, USA Trial Phase 3, ZUMA-7 Conference ASH 2021 Type News article
4 February 2022 10:10
Expert Dr Michael R. Bishop, David and Etta Jonas Center for Cellular Therapy, University of Chicago, USA Trial Phase 3, BELINDA Conference ASH 2021 Type News article
4 February 2022 10:03
Expert Dr Mahmoud Elsawy, Dalhousie University, Halifax, USA Trial Phase 3, ZUMA-7 Conference ASH 2021 Type News article
4 February 2022 09:48
ASH 2021
Editor Prof. Gert Ossenkoppele, Amsterdam UMC, the Netherlands Conference ASH 2021
4 February 2022 12:19
Presented By Dr Inge van der Sluis, Princess MƔxima Center for Pediatric Oncology, the Netherlands Conference ASH 2021 Type Peer-reviewed article
4 February 2022 12:00
Presented By Dr Sumit Gupta, University of Toronto, Canada Trial COG ALL Conference ASH 2021 Type Peer-reviewed article
4 February 2022 11:59
Presented By Prof. Patrice Chevallier, Nantes University Hospital, France Trial Phase 2, EWALL-INO Conference ASH 2021 Type Peer-reviewed article
4 February 2022 11:57
Presented By Dr Sujith Samarasinghe, Great Ormond Street Hospital, UK Trial UKALL 2003 Conference ASH 2021 Type Peer-reviewed article
4 February 2022 11:55
Presented By Dr Hartmut Dƶhner, UniversitƤtsklinikum Ulm, Germany Trial Phase 2, AMLSG 16-10 Conference ASH 2021 Type Peer-reviewed article
4 February 2022 11:53
Presented By Dr Justin Grenet, Weill Cornell Medical Center, NY, USA Conference ASH 2021 Type Peer-reviewed article
4 February 2022 11:51
Presented By Dr Naval Daver, MD Anderson Cancer Center, TX, USA Trial Phase 1/2 Conference ASH 2021 Type Peer-reviewed article
4 February 2022 11:49
Presented By Dr Patrick Reville, MD Anderson Cancer Center, TX, USA Trial Phase 2 Conference ASH 2021 Type Peer-reviewed article
4 February 2022 11:48
Presented By Dr Musa Yilmaz, MD Anderson Cancer Center, TX, USA Conference ASH 2021 Type Peer-reviewed article
4 February 2022 11:46
Presented By Dr David Sallman, H. Lee Moffitt Cancer Center, FL, USA Trial Phase 2 Conference ASH 2021 Type Peer-reviewed article
4 February 2022 11:44
Presented By Dr Elsa Bernard, Memorial Sloan Kettering Cancer Center, NY, USA Conference ASH 2021 Type Peer-reviewed article
4 February 2022 11:43
Presented By Dr Paolo Ghia, UniversitĆ Vita-Salute San Raffaele, Italy Trial Phase 2, CAPTIVATE Conference ASH 2021 Type Peer-reviewed article
4 February 2022 11:41
Presented By Prof. Constantine Tam, Peter MacCallum Cancer Centre, Australia Trial Phase 3, SEQUOIA Conference ASH 2021 Type Peer-reviewed article
4 February 2022 11:39
Presented By Dr Meghan Thompson, Memorial Sloan Cancer Center, NY, USA Conference ASH 2021 Type Peer-reviewed article
4 February 2022 11:36
Presented By Dr Jacob Laubach, Dana-Farber Cancer Institute, MA, USA Trial Phase 2, GRIFFIN Conference ASH 2021 Type Peer-reviewed article
4 February 2022 11:30
Presented By Prof. Philippe Moreau, University Hospital of Nantes, France Trial Phase 1/2, MajesTEC-1 Conference ASH 2021 Type Peer-reviewed article
4 February 2022 11:26
Presented By Dr SigrĆŗn ThorsteinsdĆ³ttir, University of Iceland, Iceland Trial iStopMM Conference ASH 2021 Type Peer-reviewed article
4 February 2022 11:25
Presented By Dr Eileen Boyle, NYU Langone Health, NY, USA Conference ASH 2021 Type Peer-reviewed article
4 February 2022 11:22
Presented By Dr Ajai Chari, Mount Sinai School of Medicine, NY, USA Trial Phase 1, TRIMM-2 Conference ASH 2021 Type Peer-reviewed article
4 February 2022 11:16
Presented By Dr Michael Bishop, University of Chicago, IL, USA Trial Phase 3, BELINDA Conference ASH 2021 Type Peer-reviewed article
4 February 2022 11:11
Presented By Dr Frederick Locke, Moffitt Cancer Cancer, FL, USA Trial Phase 3, ZUMA-7 Conference ASH 2021 Type Peer-reviewed article
4 February 2022 11:09
Presented By Dr Emmanuel Bachy, Hospices Civils de Lyon, France Conference ASH 2021 Type Peer-reviewed article
4 February 2022 11:01
Presented By Prof. HervƩ Tilly, University of Rouen, France Trial Phase 3, POLARIX Conference ASH 2021 Type Peer-reviewed article
4 February 2022 10:56
Presented By Dr Jurik Mutter, University Medical Center Freiburg, Germany Conference ASH 2021 Type Peer-reviewed article
4 February 2022 10:53
Presented By Dr Alba Rodriguez-Meira, University of Oxford, UK Conference ASH 2021 Type Peer-reviewed article
4 February 2022 10:51
Presented By Dr Giuseppe Loscocco, University of Florence, Italy Conference ASH 2021 Type Peer-reviewed article
4 February 2022 10:51
Presented By Dr Zhuo-Yu An, Peking University Peopleās Hospital, China Trial Phase 2, TARGET 020 Conference ASH 2021 Type Peer-reviewed article
4 February 2022 10:50
Presented By Prof. Matthieu Mahevas, HĆ“pital Henri-Mondor, France Trial STOPAGO Conference ASH 2021 Type Peer-reviewed article
4 February 2022 10:50
Presented By Dr Alok Srivastava, Christian Medical College Vellore, India Trial Phase 3, ATLAS-A/B Conference ASH 2021 Type Peer-reviewed article
4 February 2022 10:50
Presented By Dr Guy Young, University of Southern California, CA, USA Trial Phase 3, ATLAS-INH Conference ASH 2021 Type Peer-reviewed article
4 February 2022 10:50
Presented By Dr Lynn Malec, Versiti Blood Research Institute, WI, USA Trial verITI-8 Conference ASH 2021 Type Peer-reviewed article
4 February 2022 10:50
Presented By Dr Hind Bouzid, Stanford University, CA, USA Conference ASH 2021 Type Peer-reviewed article
4 February 2022 10:49
Presented By Dr Margarete Fabre, University of Cambridge, UK Conference ASH 2021 Type Peer-reviewed article
4 February 2022 10:49
Presented By Dr Rachel Giles, Medicom Conference ASH 2021
4 January 2022 08:00
EHA 2021
Editor Prof. Gert Ossenkoppele, Amsterdam UMC, the Netherlands Conference EHA 2021
5 August 2021 16:10
Presented By Prof. Ali Taher, American University of Beirut Medical Center, Lebanon Trial Phase 2, BEYOND Conference EHA 2021 Type Peer-reviewed article
5 August 2021 15:43
Presented By Dr Erfan Nur, Amsterdam University Medical Center, the Netherlands Conference EHA 2021 Type Peer-reviewed article
5 August 2021 15:38
Presented By Dr Haydar Frangoul, Sarah Cannon Research Institute, USA Conference EHA 2021 Type Peer-reviewed article
5 August 2021 15:32
Presented By Dr MarĆa Mingot-Castellano, Hospital Universitario Virgen del RocĆo, Spain Trial HERCULES; TITAN Conference EHA 2021 Type Peer-reviewed article
5 August 2021 15:25
Presented By Prof. Dick Oepkes, Leiden University Medical Centre, the Netherlands Conference EHA 2021 Type Peer-reviewed article
5 August 2021 15:21
Presented By Prof. Waleed Ghanima, University of Oslo, Norway Trial Phase 3, FIT-1,-2,-3 Conference EHA 2021 Type Peer-reviewed article
5 August 2021 15:16
Presented By Prof. Marcel Levi, Amsterdam University Medical Centre, the Netherlands Conference EHA 2021 Type Peer-reviewed article
5 August 2021 15:11
Presented By Dr Yu Hu, Wuhan Union Hospital, China Conference EHA 2021 Type Peer-reviewed article
5 August 2021 15:07
Presented By Prof. Andreas Greinacher, UniversitƤtsmedizin Greifswald, Germany Conference EHA 2021 Type Peer-reviewed article
5 August 2021 15:03
Presented By Prof. Sabine Eichinger, Medical University Hospital of Vienna, Austria Conference EHA 2021 Type Peer-reviewed article
5 August 2021 14:58
Presented By Prof. Francesco Passamonti, University of Insubria, Italy Trial PERSIST; SIMPLIFY; BOREAS Conference EHA 2021 Type Peer-reviewed article
5 August 2021 14:54
Presented By Prof. Noopur Raje, Massachusetts General Cancer Center, USA Trial KarMMA; CARTITUDE-1; UNIVERSAL Conference EHA 2021 Type Peer-reviewed article
5 August 2021 14:49
Presented By Prof. Thierry Facon, University of Lille, France Trial Phase 3, MAIA Conference EHA 2021 Type Peer-reviewed article
5 August 2021 14:46
Presented By Prof. Efstathios Kastritis, National and Kapodistrian University of Athens, Greece Trial Phase 3, ANDROMEDA Conference EHA 2021 Type Peer-reviewed article
5 August 2021 14:31
Presented By Prof. Andrew Wei, Alfred Hospital and Monash University, Australia Conference EHA 2021 Type Peer-reviewed article
5 August 2021 14:27
Presented By Prof. Susanne SauĆele, Heidelberg University, Germany Trial EURO-SKI Conference EHA 2021 Type Peer-reviewed article
5 August 2021 14:13
Presented By Prof. Peter Hillmen, University of Leeds, UK Trial Phase 3, ALPINE Conference EHA 2021 Type Peer-reviewed article
5 August 2021 14:08
Presented By Prof. Hartmut Dƶhner, UniversitƤtsklinikum Ulm, Germany Trial Phase 2, QUAZAR AML-001 Conference EHA 2021 Type Peer-reviewed article
5 August 2021 13:59
Presented By Prof. Nigel Russell, Guy's Hospital, UK Trial AML16; AML18 Conference EHA 2021 Type Peer-reviewed article
5 August 2021 13:55
Presented By Dr Jeff Sharman, US Oncology Network, USA Trial Phase 3, ELEVATE-TN Conference EHA 2021 Type Peer-reviewed article
5 August 2021 13:50
Presented By Prof. Peter Hillmen, St Jamesās University Hospital, UK Trial Phase 3, ELEVATE-RR Conference EHA 2021 Type Peer-reviewed article
5 August 2021 13:43
Presented By Dr Mark-David Levin, Albert Schweitzer Hospital, the Netherlands Trial Phase 2, HOVON 139/GiVe Conference EHA 2021 Type Peer-reviewed article
5 August 2021 13:38
Presented By Prof. Arnon Kater, Amsterdam University Medical Centres, the Netherlands Trial Phase 2, GLOW Conference EHA 2021 Type Peer-reviewed article
5 August 2021 13:33
Presented By Dr Marc AndrƩ, Centre Hospitalier Universitaire UCL Namur, Belgium Trial CheckMate 205; KEYNOTE-087 Conference EHA 2021 Type Peer-reviewed article
5 August 2021 12:26
Presented By Dr Gerald Illerhaus, Klinikum der Landeshauptstadt Stuttgart, Germany Trial Phase 2, IELSG32 Conference EHA 2021 Type Peer-reviewed article
5 August 2021 12:05
Presented By Dr Moshe Yair Levy, Texas Oncology-Baylor Charles A. Sammons Cancer Center, USA Conference EHA 2021 Type Peer-reviewed article
5 August 2021 11:55
Presented By Dr Bastian von Tresckow, University Hospital Essen, Germany Trial ZUMA-5; ELARA Conference EHA 2021 Type Peer-reviewed article
5 August 2021 11:47
Presented By Prof. John Gribben, Barts Cancer Institute, UK Trial ZUMA-5; SCHOLAR-5 Conference EHA 2021 Type Peer-reviewed article
5 August 2021 11:18
Presented By Prof. Marco Ladetto, University del Piemonte Orientale, Italy Trial LOTIS-2 Conference EHA 2021 Type Peer-reviewed article
5 August 2021 11:17
Presented By Dr Rachel Giles, Medicom Conference EHA 2021
1 July 2021 13:58
Presented By Prof. Arnon Kater, Amsterdam University Medical Centre, the Netherlands Trial Phase 3, GLOW Conference EHA 2021
16 June 2021 11:18
Presented By Prof. Sabine Eichinger, Medical University Hospital of Vienna, Austria Conference EHA 2021
16 June 2021 11:06
Presented By Dr Mark-David Levin, Albert Schweitzer Hospital, the Netherlands Trial Phase 2, HOVON 139/GiVe Conference EHA 2021
16 June 2021 10:52
Presented By Prof. Peter Hillmen, St Jamesās University Hospital, UK Trial Phase 3, ELEVATE-RR Conference EHA 2021
16 June 2021 09:50
Presented By Dr Moshe Yair Levy, Texas Oncology-Baylor Charles A. Sammons Cancer Center, TX, US Trial Phase 2 Conference EHA 2021
16 June 2021 09:25
ASH 2020
Editor Prof. Gert Ossenkoppele, Amsterdam UMC, the Netherlands Conference ASH 2020
22 February 2021 11:58
Presented By Dr Angelo Belotti, ASST Spedali Civili di Brescia, Italy Conference ASH 2020 Type Peer-reviewed article
18 February 2021 10:43
Presented By Dr Hira Mian, McMaster University, Canada Conference ASH 2020 Type Peer-reviewed article
18 February 2021 10:42
Presented By Prof. Thierry Facon, University Hospital Lille, France Trial Phase 3, TOURMALINE-MM2 Conference ASH 2020 Type Peer-reviewed article
18 February 2021 10:37
Presented By Dr Francesca Gay, GIMEMA, European Myeloma Network, Italy Trial Phase 2, FORTE Conference ASH 2020 Type Peer-reviewed article
18 February 2021 10:35
Presented By Prof. Michele Cavo, University of Bologna, Italy Trial Phase 3, EMN02/HO95 Conference ASH 2020 Type Peer-reviewed article
18 February 2021 10:29
Presented By Prof. Meletios Dimopoulos, University of Athens, Greece Trial Phase 3, APOLLO Conference ASH 2020 Type Peer-reviewed article
18 February 2021 10:26
Presented By Dr Enrique Ocio, University Hospital MarquƩs de Valdecilla, Spain Trial Phase 1/2, ANCHOR (OP-104) Conference ASH 2020 Type Peer-reviewed article
18 February 2021 10:22
Presented By Dr Adam Cohen, University of Pennsylvania, Philadelphia, USA Trial Phase 1, GO39775 Conference ASH 2020 Type Peer-reviewed article
18 February 2021 10:20
Presented By Dr Yi Lin, Mayo Clinic, Minnesota, USA Trial Phase 1, CRB-401 Conference ASH 2020 Type Peer-reviewed article
18 February 2021 10:17
Presented By Dr Robbie Majzner, Stanford University, California, USA Conference ASH 2020 Type Peer-reviewed article
18 February 2021 10:15
Presented By Dr Caron Jacobson, Dana Farber Cancer Institute, Massachusetts, USA Trial Phase 2, ZUMA-5 Conference ASH 2020 Type Peer-reviewed article
18 February 2021 10:12
Presented By Dr Rami S. Komrokji (H. Lee Moffitt Cancer Center and Research Institute, Florida, USA) & Dr Michael R. Grunwald (Levine Cancer Institute, North Carolina, USA) Trial MOST Conference ASH 2020 Type Peer-reviewed article
18 February 2021 10:08
Presented By Dr Srdan Verstovsek, MD Anderson Cancer Center, Texas, USA Trial SIMPLIFY Conference ASH 2020 Type Peer-reviewed article
18 February 2021 10:05
Presented By Dr Naveen Pemmaraju, MD Anderson Cancer Center, Texas, USA Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:59
Presented By Dr Jyoti Nangalia, University of Cambridge, United Kingdom Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:53
Presented By Dr Charlotte Bradbury, University of Bristol, United Kingdom Trial FLIGHT Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:50
Presented By Dr Catherine Broome, MedStar Georgetown University Hospital, Washington DC, USA Trial Phase 1 Conference ASH 2020
18 February 2021 09:46
Presented By Dr David J. Kuter, Massachusetts General Hospital & Harvard Medical School, USA Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:42
Presented By Dr Susanne Ghandili, University Medical Center Hamburg-Eppendorf, Germany Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:34
Presented By Dr Delphine Rea, UniversitƩ de Paris, France Trial CANDID Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:32
Presented By Dr Spyridoula Vasileiou, Baylor College of Medicine, USA Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:30
Presented By Prof. William A. Wood, University of North Carolina, USA Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:28
Presented By Dr Danielle Fredman, Sheba Medical Center, Israel Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:26
Presented By Dr Lori Muffly, Stanford University, California, USA Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:24
Presented By Prof. Sebastian Giebel, Maria SkÅodowska-Curie National Research Institute of Oncology, Poland Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:23
Presented By Dr Shannon Murphy, Dalhousie University, Canada Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:21
Presented By Dr Shukaib Arslan, City Of Hope Helford Clinical Research Hospital, California, USA Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:19
Presented By Ms Jacqueline S. Garcia, Dana-Farber Institute, Massachusetts, USA Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:18
Presented By Prof. Tim BrĆ¼mmendorf, RWTH Aachen University, Germany Trial Phase 3, BFORE Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:17
Presented By Dr Maximilian Stahl, Memorial Sloan Kettering Cancer Center, New York, USA Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:15
Presented By Dr Alexander Perl, University of Pennsylvania, USA Trial Phase 3, QuANTUM-R Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:14
Presented By Dr David Sallman, H. Lee Moffitt Cancer Center and Research Institute, Florida, USA Trial Phase 1 Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:11
Presented By Dr Ibrahim Aldoss, City of Hope Medical Center, California, USA Trial Phase 1/2 Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:09
Presented By Dr Hagop Kantarjian, MD Anderson Cancer Center, Texas, USA Trial OPTIC, PACE Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:08
Presented By Dr Alexander Perl, University of Pennsylvania, USA Trial CHRYSALIS, ADMIRAL Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:07
Presented By Dr Tapan Kadia, MD Anderson Cancer Center, Texas, USA Conference ASH 2020 Type Peer-reviewed article
18 February 2021 09:05
Presented By Dr Andreas Hochhaus, UniversitƤtsklinikum Jena, Germany Trial Phase 3, ASCEMBL Conference ASH 2020 Type Peer-reviewed article
18 February 2021 08:58
Presented By Prof. Jan Burger, MD Anderson Cancer Center, Texas, USA Trial Phase 3, RESONATE-2, iLLUMINATE Conference ASH 2020 Type Peer-reviewed article
18 February 2021 08:54
Presented By Prof. Steven Pipe, University of Michigan, USA Trial Phase 3, HOPE-B Conference ASH 2020 Type Peer-reviewed article
18 February 2021 08:25
Presented By Dr Kate Khair, Great Ormond Street Hospital for Children, UK Trial CHESS Paediatrics Conference ASH 2020 Type Peer-reviewed article
18 February 2021 08:22
Presented By Dr Haydar Frangoul, Sarah Cannon Research Institute, USA Trial CLIMB THAL-111 & CLIMB SCD-121 Conference ASH 2020 Type Peer-reviewed article
18 February 2021 08:18
Presented By Prof. Olivier Hermine, UniversitƩ de Paris, France Trial Phase 3, BELIEVE Conference ASH 2020 Type Peer-reviewed article
18 February 2021 08:12
Presented By Dr Rachel Giles, Medicom Conference ASH 2020
9 December 2020 14:44
EHA 2020
Presented By Dr Rachel Giles, Medicom Conference EHA 2020
9 September 2020 14:29
Editor Prof. Gert Ossenkoppele, Amsterdam UMC, the Netherlands Conference EHA 2020
9 September 2020 14:12
Presented By Dr Courtney Di Nardo, MD Anderson Cancer Centre, USA Trial Phase 3, VIALE-A Conference EHA 2020 Type Peer-reviewed article
9 September 2020 13:25
Presented By Prof. Andrew Wei, Monash University, Australia Trial Phase 3, VIALE-C Conference EHA 2020 Type Peer-reviewed article
9 September 2020 13:22
Presented By Dr AbhishekĀ Maiti, University of Texas MD Anderson Cancer Centre, USA Trial Phase 2 Conference EHA 2020 Type Peer-reviewed article
9 September 2020 13:18
Presented By Prof. Naval Draver, University of Texas MD Anderson Cancer Centre, USA Trial Phase 1 Conference EHA 2020 Type Peer-reviewed article
9 September 2020 13:14
Presented By Prof. Timothy Hughes, University of Adelaide, Australia Trial Phase 1 Conference EHA 2020 Type Peer-reviewed article
9 September 2020 13:08
Presented By Dr Hjalmar Flygt, Uppsala University Hospital, Sweden Conference EHA 2020 Type Peer-reviewed article
9 September 2020 13:03
Presented By Prof. Uwe Platzbecker, University Clinic Leipzig, Germany Trial Phase 2, IMerge Conference EHA 2020 Type Peer-reviewed article
9 September 2020 12:59
Presented By Dr Courtney Di Nardo, MD Anderson Cancer Centre, USA Trial Phase 2, AG-221-AML-005 Conference EHA 2020 Type Peer-reviewed article
9 September 2020 12:55
Presented By Dr Peter Borchmann, University Hospital of Cologne, Germany Trial Phase 3, HD17 Conference EHA 2020 Type Peer-reviewed article
9 September 2020 12:51
Presented By Prof. Pier Luigi Zinzani, University of Bologna, Italy Trial Phase 3, KEYNOTE-204 Conference EHA 2020 Type Peer-reviewed article
9 September 2020 12:38
Presented By Dr Martin Hutchings, Copenhagen University Hospital, Denmark Trial Phase 1/2, GEN3013 Conference EHA 2020 Type Peer-reviewed article
9 September 2020 12:30
Presented By Prof. John Byrd, Ohio State University Comprehensive Cancer Centre, USA Trial Phase 2, ACE-CL-001, ASCEND Conference EHA 2020 Type Peer-reviewed article
9 September 2020 12:19
Presented By Prof. Meletios Dimopoulos, University of Athens, Greece Trial Phase 3, ASPEN Conference EHA 2020 Type Peer-reviewed article
9 September 2020 12:10
Expert Prof. Arnon Kater, Amsterdam University Medical Center, the Netherlands Trial Phase 3, VENICE 1 Conference EHA 2020 Type Peer-reviewed article
9 September 2020 11:35
Expert Dr Hui Wang, Hebei Yanda Ludaopei Hospital, China Conference EHA 2020 Type Peer-reviewed article
9 September 2020 11:02
Presented By Dr Efstathios Kastritis, National and Kapodistrian University of Athens, Greece Trial Phase 3, ANDROMEDA Conference EHA 2020 Type Peer-reviewed article
9 September 2020 10:49
Presented By Prof. Philippe Moreau, University Hospital of Nantes, France Trial Phase 3, IKEMA Conference EHA 2020 Type Peer-reviewed article
9 September 2020 10:26
Presented By Prof. JesĆŗs San Miguel, University of Navarra, Spain Conference EHA 2020 Type Peer-reviewed article
9 September 2020 10:19
Presented By Prof. Robert Zeiser, University Hospital Freiburg, Germany Trial Phase 3, GRAVITAS-301 Conference EHA 2020 Type Peer-reviewed article
9 September 2020 10:02
Presented By Prof. Robert Zeiser, University Hospital Freiburg, Germany Trial Phase 3, REACH2 Conference EHA 2020 Type Peer-reviewed article
9 September 2020 09:57
Presented By Dr George Goshua, Yale University, USA Conference EHA 2020 Type Peer-reviewed article
28 August 2020 15:54
Presented By Prof. Peter Hillmen, St James's University Hospital, UK Trial Phase 3, PEGASUS trial Conference EHA 2020 Type Peer-reviewed article
28 August 2020 15:53
Presented By Dr Kevin HM Kuo, Princess Margaret Cancer Centre, Canada Trial Phase 1 Conference EHA 2020 Type Peer-reviewed article
28 August 2020 15:46
Presented By Dr Julie Kanter, University of Alabama, USA Trial HGB-206 Group C study Conference EHA 2020 Type Peer-reviewed article
28 August 2020 12:37
Presented By Prof. Elias Jabbour , University of Texas MS Anderson Cancer Centre, USA Trial Phase 1 Conference EHA 2020 Type Peer-reviewed article
28 August 2020 12:23
Presented By Dr Carolina Vincente-DueƱas, Institute of Biomedical Research of Salamanca, Spain Conference EHA 2020 Type Peer-reviewed article
28 August 2020 12:15
Presented By Dr Simon Renders, German Cancer Research Centre, Germany Conference EHA 2020 Type Peer-reviewed article
28 August 2020 12:12
Presented By Prof. Christine Mauz-Kƶrholz, Justus-Liebig-UniversitƤt GieĆen, Germany Trial Phase 2, Checkmate 744 Conference EHA 2020 Type Peer-reviewed article
28 August 2020 12:09
Presented By Dr Bruno Galy, German Cancer Research Centre, Germany Conference EHA 2020 Type Peer-reviewed article
28 August 2020 12:08
ASH 2019
Presented By Dr Lena Winestone, UCSF Benioff Childrenās Hospital, USA Trial Phase 3, AAML0531 and AAML1031 Conference ASH 2019 Type Peer-reviewed article
5 March 2020 23:55
Presented By Dr Annoek Broers, Erasmus MC Cancer Institute, the Netherlands Conference ASH 2019 Type Peer-reviewed article
5 March 2020 23:53
Presented By Prof. Patrick A. Brown, Johns Hopkins Kimmel Cancer Center, Baltimore, USA Trial Phase 3, AALL1331 Conference ASH 2019 Type Peer-reviewed article
5 March 2020 23:15
Presented By Dr Christine Chen, Princess Margaret Cancer Centre, University of Toronto, Canada Trial MM-003, STOMP Conference ASH 2019 Type Peer-reviewed article
5 March 2020 22:59
Presented By Dr Melanie Castro-Mollo, Icahn School of Medicine at Mount Sinai, USA Conference ASH 2019 Type Peer-reviewed article
5 March 2020 22:39
Presented By Dr Alexander Rƶth, University of Duisburg-Essen, Germany Trial Phase 3, CARDINAL Conference ASH 2019 Type Peer-reviewed article
5 March 2020 22:36
Presented By Dr Andrew Wei, Alfred Hospital, Australia Trial Phase 3, QUAZAR AML-001 Conference ASH 2019 Type Peer-reviewed article
5 March 2020 21:39
Presented By Dr Karl Kilgore, Avalere, USA Conference ASH 2019 Type Peer-reviewed article
5 March 2020 21:07
Presented By Dr David Williams, Boston Childrenās Hospital, USA Conference ASH 2019 Type Peer-reviewed article
5 March 2020 20:45
Presented By Dr Deepu Madduri, Mount Sinai Medical Center, USA Trial Phase 1/2, CARTITUDE-1 Conference ASH 2019 Type Peer-reviewed article
5 March 2020 20:29
Presented By Prof. Guy Young, Children's Hospital Los Angeles, USA Trial Phase 3, EINSTEIN-Jr Conference ASH 2019 Type Peer-reviewed article
5 March 2020 20:19
Presented By Prof. Richard Onalo, University of Abuja, Nigeria Conference ASH 2019 Type Peer-reviewed article
5 March 2020 20:18
Presented By Prof. Saad Usmani, UNC-Chapel Hill School of Medicine, USA Trial Phase 3, CANDOR Conference ASH 2019 Type Peer-reviewed article
5 March 2020 19:49
Presented By Prof. Jordan Schaefer, University of Michigan, USA Conference ASH 2019 Type Peer-reviewed article
5 March 2020 19:23
Presented By Dr Abby Statler, Cleveland Clinic, USA Conference ASH 2019 Type Peer-reviewed article
5 March 2020 19:10
Presented By Prof. Jean-Jacques Kiladjian, Saint Louis Hospital, France Trial PROUD-PV Conference ASH 2019 Type Peer-reviewed article
5 March 2020 18:53
Presented By Prof. Adrian Ochsenbein, Bern University Hospital, Switzerland Conference ASH 2019 Type Peer-reviewed article
5 March 2020 17:01
Presented By Prof. Yu Hu, Huazhong University of Science and Technology, China Conference ASH 2019 Type Peer-reviewed article
5 March 2020 16:31
Presented By Dr Maria Vazquez, MD Anderson Cancer Center, Houston, USA Conference ASH 2019 Type Peer-reviewed article
5 March 2020 16:26
Presented By Dr Maria Victoria Mateos, University Hospital of Salamanca, Spain Trial Phase 3, ALCYONE Conference ASH 2019 Type Peer-reviewed article
5 March 2020 16:16
Presented By Prof. Uwe Platzbecker, University Hospital Carl Gustav Carus, Germany Trial Phase 2, RELAZA2 Conference ASH 2019 Type Peer-reviewed article
5 March 2020 16:04
Presented By Dr Shuquan Rao, Harvard Medical School, USA Conference ASH 2019 Type Peer-reviewed article
5 March 2020 15:43
Presented By Dr Niketa Shah, Yale University, USA Conference ASH 2019 Type Peer-reviewed article
5 March 2020 15:20
Presented By Prof. Aaron Gerds, Cleveland Clinic Taussig Cancer Institute, USA Conference ASH 2019 Type Peer-reviewed article
5 March 2020 15:11
Presented By Dr Jennifer Myers SanMiguel, The Jackson Laboratory, USA Conference ASH 2019 Type Peer-reviewed article
5 March 2020 14:47
Editor Prof. Gert Ossenkoppele, VU University Medical Center, the Netherlands Conference ASH 2019
5 March 2020 14:27
Presented By Prof. Gill Singh, University of Hong Kong, China Conference ASH 2019 Type Peer-reviewed article
5 March 2020 14:13
Presented By Dr Xiaowen Tang; Dr James Foran Trial Phase 2, ECOG-ACRIN E2906 Conference ASH 2019 Type Peer-reviewed article
5 March 2020 13:16
Presented By Prof. Stephen Schuster, University of Pennsylvania, USA Conference ASH 2019 Type Peer-reviewed article
5 March 2020 09:50
Presented By Dr Jode Goodridge, Fate Therapeutics, USA Conference ASH 2019 Type Peer-reviewed article
5 March 2020 09:38
EHA 2019
Presented By Dr Jo Howard, Kingās College London, United Kingdom Trial Phase 3, HOPE Conference EHA 2019 Type Peer-reviewed article
9 August 2019 23:49
Presented By Prof. Phillippe Moreau, University Hospital of Nantes, France Trial Phase 3, CASSIOPEIA Conference EHA 2019 Type Peer-reviewed article
9 August 2019 23:30
Conference EHA 2019
9 August 2019 23:23
Presented By Dr Christopher Hourigan, NIH, USA Conference EHA 2019 Type Peer-reviewed article
9 August 2019 23:05
Presented By Dr Sophia Gialesaki, Hannover Medical School, Germany Conference EHA 2019 Type Peer-reviewed article
9 August 2019 23:00
Presented By Dr Biree Andemariam, UConn Health, USA Conference EHA 2019 Type Peer-reviewed article
9 August 2019 22:50
Presented By Dr Eugen Tausch, University of Ulm, Germany Trial CLL14 Conference EHA 2019 Type Peer-reviewed article
9 August 2019 22:38
Presented By Prof. Hermann Einsele, University of WĆ¼rzburg, Germany Conference EHA 2019 Type Peer-reviewed article
9 August 2019 22:34
Presented By Dr Alexander Perl, University of Pennsylvania, USA Trial Phase 3, ADMIRAL Conference EHA 2019 Type Peer-reviewed article
9 August 2019 22:14
Presented By Dr Antonella Nai, San Raffaele Scientific Institute, Italy Conference EHA 2019 Type Peer-reviewed article
9 August 2019 22:03
Presented By Dr Francoise Bernaudin, Intercommunal Hospital Center de CrƩteil, France Trial DREPAGREFFE Conference EHA 2019 Type Peer-reviewed article
9 August 2019 21:52
Presented By Prof. Mohamad Mohty, Saint-Antoine Hospital and University Pierre & Marie Curie, France Trial Phase 2, ELIANA Conference EHA 2019 Type Peer-reviewed article
9 August 2019 21:36
Presented By Prof. MarĆa-Victoria Mateos , University of Salamanca, Spain Trial Phase 3, COLUMBA Conference EHA 2019 Type Peer-reviewed article
9 August 2019 21:36
Presented By Prof. Gail Roboz, Weill Cornell Medicine, USA Trial Phase 1, AMV564-101 Conference EHA 2019 Type Peer-reviewed article
9 August 2019 21:18
Presented By Dr Steven Horwitz , Memorial Sloan Kettering Cancer Center, USA Trial Phase 3, ECHELON-1 Conference EHA 2019 Type Peer-reviewed article
9 August 2019 20:49
Presented By Prof. Michel Attal, University Institute Cancer Toulouse Oncopole, France Trial Phase 3, ICARIA-MM Conference EHA 2019 Type Peer-reviewed article
9 August 2019 20:38
Presented By Dr David Sallman, Moffitt Cancer Center, USA Trial 5F9005 Conference EHA 2019 Type Peer-reviewed article
9 August 2019 20:20
Presented By Dr Hitoshi Takizawa, Kumamoto University, Japan Conference EHA 2019 Type Peer-reviewed article
9 August 2019 20:19
Presented By Dr Roberta Di Blasi, Hospital Saint-Louis, France Trial JULIET and ZUMA1 Conference EHA 2019 Type Peer-reviewed article
9 August 2019 19:55
Presented By Prof. Lutz Renders, Klinikum Rechts der Isar, Germany Conference EHA 2019 Type Peer-reviewed article
9 August 2019 19:54
Presented By Prof. Raymond Comenzo, Tufts University, USA Trial Phase 3, ANDROMEDA Conference EHA 2019 Type Peer-reviewed article
9 August 2019 19:40
Presented By Prof. Wojciech Jurczak, Jagiellonian University, Poland Conference EHA 2019 Type Peer-reviewed article
9 August 2019 17:13
Presented By Dr Petra Langerbeins, University of Cologne, Germany Trial Phase 3, CLL12 Conference EHA 2019 Type Peer-reviewed article
9 August 2019 16:26
Presented By Dr Paolo Ghia, Vita-Salute San Raffaele University, Italy Trial Phase 3, ASCEND Conference EHA 2019 Type Peer-reviewed article
9 August 2019 15:28
Presented By Prof. Jorge Cortes, University of Texas MD Anderson Cancer Center, USA Trial Phase 1 Conference EHA 2020 Type Peer-reviewed article
9 August 2019 12:22
Editor Prof. Gert Ossenkoppele, VU University Medical Center, Amsterdam, the Netherlands Conference EHA 2019
9 August 2019 11:53
Expert Prof. Pieter Sonneveld, Erasmus Medical Center in Rotterdam, the Netherlands Conference EHA 2019
9 August 2019 09:59
Presented By Dr Shaji Kumar, Mayo Clinic, USA Trial Phase 3, BELLINI Conference EHA 2019 Type Peer-reviewed article
9 August 2019 09:42
Presented By Prof. Pierre Fenaux, HĆ“pital Saint-Louis, France Trial Phase 3, ASTRAL-1 Conference EHA 2019 Type Peer-reviewed article
9 August 2019 09:25
Presented By Dr Olivier Hermine, Necker Hospital, France Trial Phase 1/2, HGB-206 Conference EHA 2019 Type Peer-reviewed article
9 August 2019 08:25
Presented By Dr Kirsten Fischer, University of Cologne, Germany Trial Phase 3, CLL14 Conference EHA 2019 Type Peer-reviewed article
9 June 2019 23:28
ASH 2018
Editor Prof. Gert Ossenkoppele, VU University Medical Center, the Netherlands Conference ASH 2018
4 December 2018 10:29
EHA 2018
Editor Prof. Gert Ossenkoppele, VU University Medical Center, the Netherlands Conference EHA 2018
28 June 2018 10:54
Expert Prof. Pieter Sonneveld, Erasmus Medical Centre, the Netherlands Conference EHA 2018
24 June 2018 10:52
EHA 2017
Editor Prof. Eliezer Rachmilewitz, Edith Wolfson Medical Center, Israel Conference EHA 2017
25 June 2017 10:46
